EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The FDA’s plan to phase out animal testing

Sara Gerke, Jacob Balamut, Jennifer K Wagner

Trends in Biotechnology · 2026-08 · 44 (8) · 2178-2181

DOI: 10.1016/j.tibtech.2025.12.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Biotechnology, 2026-08. Verfasst von Sara Gerke und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Law and European Union Center, University of Illinois Urbana-Champaign, Champaign, IL, USA. Electronic address: gerke@illinois.edu. Hauptthemen laut MEDLINE: Animal Testing Alternatives, United States Food and Drug Administration. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, NIMH NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Replacing animal testing through 'New Approach Methodologies' holds promise for developing cheaper and safer drugs without animal suffering. However, such an approach should be implemented carefully, and it cannot be rushed. We discuss the FDA Modernization Act 2.0 and 3.0 and the FDA's roadmap to phase out animal testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Animal Testing AlternativesUnited States Food and Drug AdministrationAnimalsHumansUnited States

Stichwörter der Autor:innen

FDAFDA Modernization Act 2.0 and 3.0NAMsNew Approach Methodologiesanimal testing

Autor:innen und Institutionen

  • College of Law and European Union Center, University of Illinois Urbana-Champaign, Champaign, IL, USA. Electronic address: gerke@illinois.edu.
  • Project BLAST: Bioethical, Legal, and Anthropological Study of Technologies, University of Illinois Urbana-Champaign, Champaign, IL, USA.
  • School of Engineering Design and Innovation, Penn State University, University Park, PA 16802, USA.

Förderung

  • NIBIB NIH HHS
  • NIMH NIH HHS
  • NIA NIH HHS
  • National Institute of Mental Health
  • Pennsylvania State University
  • National Institute of Biomedical Imaging and Bioengineering
  • European Commission
  • Novo Nordisk Fonden

Zitieren

APA

Gerke, S., Balamut, J., & Wagner, J. K. (2026). The FDA’s plan to phase out animal testing. Trends in Biotechnology, 44(8), 2178-2181. https://doi.org/10.1016/j.tibtech.2025.12.011

Vancouver

Gerke S, Balamut J, Wagner JK. The FDA’s plan to phase out animal testing. Trends in Biotechnology. 2026;44(8):2178-2181. doi:10.1016/j.tibtech.2025.12.011

BibTeX
@article{Gerke2026,
  author = {Gerke, Sara and Balamut, Jacob and Wagner, Jennifer K},
  title = {The FDA’s plan to phase out animal testing},
  journal = {Trends in Biotechnology},
  year = {2026},
  volume = {44},
  number = {8},
  pages = {2178--2181},
  doi = {10.1016/j.tibtech.2025.12.011}
}
Kostenlos starten →